JP2013511728A5 - - Google Patents

Download PDF

Info

Publication number
JP2013511728A5
JP2013511728A5 JP2012540089A JP2012540089A JP2013511728A5 JP 2013511728 A5 JP2013511728 A5 JP 2013511728A5 JP 2012540089 A JP2012540089 A JP 2012540089A JP 2012540089 A JP2012540089 A JP 2012540089A JP 2013511728 A5 JP2013511728 A5 JP 2013511728A5
Authority
JP
Japan
Prior art keywords
antigen
subject
antibody
stage
ovarian cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012540089A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013511728A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/057427 external-priority patent/WO2011063232A1/en
Publication of JP2013511728A publication Critical patent/JP2013511728A/ja
Publication of JP2013511728A5 publication Critical patent/JP2013511728A5/ja
Pending legal-status Critical Current

Links

JP2012540089A 2009-11-20 2010-11-19 癌のバイオマーカー Pending JP2013511728A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26323509P 2009-11-20 2009-11-20
US61/263,235 2009-11-20
PCT/US2010/057427 WO2011063232A1 (en) 2009-11-20 2010-11-19 Biomarkers of cancer

Publications (2)

Publication Number Publication Date
JP2013511728A JP2013511728A (ja) 2013-04-04
JP2013511728A5 true JP2013511728A5 (cg-RX-API-DMAC7.html) 2014-01-16

Family

ID=44060024

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012540089A Pending JP2013511728A (ja) 2009-11-20 2010-11-19 癌のバイオマーカー

Country Status (6)

Country Link
US (1) US20150005187A1 (cg-RX-API-DMAC7.html)
EP (1) EP2501845A4 (cg-RX-API-DMAC7.html)
JP (1) JP2013511728A (cg-RX-API-DMAC7.html)
AU (1) AU2010321787B2 (cg-RX-API-DMAC7.html)
CA (1) CA2781408A1 (cg-RX-API-DMAC7.html)
WO (1) WO2011063232A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102393458B (zh) * 2011-08-24 2013-12-18 绍兴市人民医院 一种早期乳腺癌血清诊断试剂
US20140186293A1 (en) * 2012-12-31 2014-07-03 University Of Louisville Research Foundation, Inc. Immunoglobulin-bound extracellular vesicles and uses thereof
CA2894538A1 (en) * 2013-01-31 2014-08-07 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Ari Autoantibody signature for the early detection of ovarian cancer
EP3281016A1 (en) * 2015-04-10 2018-02-14 Applied Proteomics Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
KR20230079198A (ko) * 2020-10-05 2023-06-05 프리놈 홀딩스, 인크. 결장 세포 증식성 장애의 조기 검출을 위한 마커

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780161B1 (fr) 1998-06-17 2000-09-29 Centre Nat Rech Scient Procede de diagnostic precoce du cancer base sur la recherche d'auto-anticorps diriges contre la proteine csk et trousse pour sa mise en oeuvre
US20030190602A1 (en) * 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
US20030119079A1 (en) 2001-09-19 2003-06-26 The Regents Of The University Of Michigan Detection and treatment of cancers of the breast
WO2003026494A2 (en) * 2001-09-28 2003-04-03 Sidney Kimmel Cancer Center Galectins-1-and-4 in tumor development
US20050158737A1 (en) * 2002-03-27 2005-07-21 Alison Banham Tumour associated antigens
GB0412301D0 (en) * 2004-06-02 2004-07-07 Diagenic As Product and method
JP2007322211A (ja) * 2006-05-31 2007-12-13 Green Peptide Co Ltd がん患者の予後予測方法
CN101657719A (zh) * 2007-01-26 2010-02-24 路易斯维尔大学研究基金会公司 检测用于诊断和表征障碍的自身抗体的方法
US8476026B2 (en) * 2008-04-01 2013-07-02 The Brigham And Women's Hospital, Inc. Biomarkers of ovarian cancer

Similar Documents

Publication Publication Date Title
Imaeda et al. Clinical utility of newly developed immunoassays for serum concentrations of adalimumab and anti-adalimumab antibodies in patients with Crohn’s disease
Invernizzi et al. Antinuclear antibodies in primary biliary cirrhosis
Sah et al. Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis
AU2015265976B2 (en) Anti-B7-H3 antibodies and diagnostic uses thereof
JP2015533788A5 (cg-RX-API-DMAC7.html)
JP2014524744A5 (cg-RX-API-DMAC7.html)
Steenholdt et al. Pre‐existing IgG antibodies cross‐reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease
WO2001020333A1 (en) Early cancer tumor marker
RU2769987C2 (ru) Анализ антител
WO2010038974A3 (ko) 이뮤노글로블린 에이 신증과 티지비엠 신증의 진단용 조성물 및 키트
JP2020510409A5 (cg-RX-API-DMAC7.html)
EP3094973B1 (en) Biomarkers
Perez Alamino et al. The great mimicker: IgG4-related disease
CN103518135A (zh) 冠状动脉疾病的生物标志物
JP2021181994A (ja) 腎疾患の検出方法
JP6991968B2 (ja) 抗ヒトヘモグロビンモノクローナル抗体若しくは抗体キット、抗ヒトヘモグロビンモノクローナル抗体固定化不溶性担体粒子、及びこれらを用いた測定試薬若しくは測定方法
KR20140100544A (ko) 전립선암 분석을 위한 조성물 및 방법
JP5726432B2 (ja) マイコプラズマ・ニューモニエ抗原測定の検出方法
ES2967740T3 (es) GDF-15 como marcador de diagnóstico de melanoma
JP7315968B2 (ja) 生物学的試料中の遊離aimの免疫学的分析方法及び対象におけるnashの検出方法
CN103842823A (zh) 用于胸膜间皮瘤患者的早期发现的分子标志物及其表达分析方法
Quinton et al. Toward the limits of sandwich immunoassay of very low molecular weight molecules
Kazuno et al. Multi-sequential surface plasmon resonance analysis of haptoglobin–lectin complex in sera of patients with malignant and benign prostate diseases
JPWO2009147999A1 (ja) IgA腎症の検査方法及び検査キット
Beneduce et al. Tumour‐specific induction of immune complexes: DCP‐IgM in hepatocellular carcinoma